Elsevier

Clinical Immunology

Volume 127, Issue 1, April 2008, Pages 107-118
Clinical Immunology

T cell subset-specific susceptibility to aging

https://doi.org/10.1016/j.clim.2007.12.002Get rights and content

Abstract

With increasing age, the competence of the immune system to fight infections and tumors declines. Age-dependent changes have been mostly described for human CD8 T cells, raising the question of whether the response patterns for CD4 T cells are different. Gene expression arrays of memory CD4 T cells yielded a similar age-induced fingerprint as has been described for CD8 T cells. In cross-sectional studies, the phenotypic changes were not qualitatively different for CD4 and CD8 T cells, but occurred much more frequently in CD8 T cells. Homeostatic stability partially explained this lesser age sensitivity of CD4 T cells. With aging, naïve and central memory CD8 T cells were lost at the expense of phenotypically distinct CD8 effector T cells, while effector CD4 T cells did not accumulate. However, phenotypic shifts on central memory T cells were also more pronounced in CD8 T cells. This distinct stability in cell surface marker expression can be reproduced in vitro. The data show that CD8 T cells are age sensitive by at least two partially independent mechanisms: fragile homeostatic control and gene expression instability in a large set of regulatory cell surface molecules.

Introduction

Failure of adaptive immunity with age is a major cause for morbidity and mortality in the elderly [1], [2]. As a highly dynamic organ, the immune system is in constant turnover, even in the absence of infections or obvious challenges with exogenous antigens [3]. Naïve T cells have a half-life of 6 to 12 months and memory T cells of 15 to 45 days [4], [5]. Thymic production of new T cells dwindles with age and does not meet the replenishment demand during adulthood [6], [7], [8]. After the ages of 40 to 50 years old, virtually the entire T-cell supply is generated from existing naïve and memory T cells [9]. In this setting, insufficient homeostatic mechanisms may lead to a progressive loss of naïve and memory T cells and contraction of T-cell receptor diversity [10], [11], [12], [13], [14]. In addition, the replicative stress associated with continuous turnover can induce cellular senescence and lead to phenotypic changes that impinge on the competence of the adaptive immune system [15], [16], [17], [18].

Both mechanisms contribute to failure to respond to new antigenic challenges, poor vaccine responses [19], [20], [21], [22] and increased morbidity with newly arising infections, such as is seen with antigenic shift or drift of the influenza virus [23], [24]. Moreover, memory T-cell responses to some persisting viruses wane—a prime example is the increased incidence of herpes zoster with age [25]. Epidemiological evidence suggests that signs of decreased immune competence first occur after the age of 50 and accelerate after the ages of 65 to 70 [20], [23], [25]. It is currently unclear which functional and phenotypic changes in the immune system occur at what ages and, in particular, whether different cell types are affected to distinct extents, possibly providing a model for the patterns of age-dependent susceptibilities for different viral infections.

Circumstantial evidence suggests that CD4 and CD8 T cells behave differently in response to aging. Oligoclonal expansions in the CD8 T-cell compartment can be readily detected with age and appear to be induced by chronic persisting viruses, in particular CMV, but also arise from uneven homeostatic proliferation [12], [15], [26], [27]. In contrast, oligoclonal expansions within the CD4 compartment are rare and preferentially found in patients with autoimmune diseases [28]; they do not reach the clonal size seen with CD8 T cells [18]. Even at the age of 65, decades after the involution of the thymus, both naïve and memory CD4 T cells are highly diverse and show no contraction in T-cell receptor diversity compared to young adults [10]. Also, the classical phenotypic change of CD28 loss, frequently encountered in CD8 T cells with age [17], is only inconsistently seen for CD4 T cells [11]. However, the molecular mechanisms regulating CD28 expression and loss appear to be identical in both T-cell subsets [29], [30], suggesting a fundamental difference in CD4 and CD8 T cells in response to aging, possibly in addition to distinct cell-specific transcriptional regulation. The objective of this study was to compare CD4 and CD8 T cells and to determine whether differences in their phenotypic response pattern to aging are explained by differences in T-cell subset homeostasis or whether CD4 and CD8 T cells are intrinsically different in controlling gene expression.

Section snippets

Study population

Peripheral blood was obtained from 140 individuals aged 20–90 years and immediately processed. The study cohort included 68 individuals age 20 to 39 years, 31 age 40 to 59, and 41 age 60 to 90 years. Exclusion criteria included the presence or a history of cancer, uncontrolled hypertension, diabetes mellitus, any chronic inflammatory or autoimmune disease, or any acute disease. Appropriate written informed consent was obtained, and the study was approved by the Emory Institutional Review Board.

Gene expression microarray studies

Differential loss of CD28 in CD8 versus CD4 T cells

Loss of CD28 expression, the dominant phenotypic change of T cells with aging, is seen much more frequently in CD8 than in CD4 T cells. Figure 1 shows a cross-sectional study of CD28 expression in different age groups. In the vast majority of individuals, lack of CD28 is a rare event in CD4 T cells, irrespective of age. There was a small increase in CD4+CD28 T-cell frequencies (p < 0.001) and increasing variance in healthy individuals older than 60 years; however, even in this age group only a

Discussion

In this manuscript, we describe that CD4 T cells are more resistant to phenotypic and functional changes with aging than CD8 T cells. CD4 and CD8 T cells undergo the same principal phenotypic shifts; however, the rate at which they occur or accumulate with age is vastly different. The increased susceptibility of CD8 T cells to age was seen for all functional subsets and for all cell surface markers tested. Diminution of naïve cells with age was drastic for CD8 T cells, but relatively minor for

Acknowledgments

This work was funded in part by grants from the National Institutes of Health (RO1 AG 15043 and RO1 AI 57266), the General Clinical Research Center (MO1 RR00039), the Noble Foundation, and the Aging Registry. The authors thank Tamela Yeargin for manuscript editing.

References (39)

  • C.M. Weyand et al.

    Functional properties of CD4+CD28− T cells in the aging immune system

    Mech. Ageing Dev.

    (1998)
  • J.M. Brenchley et al.

    Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells

    Blood

    (2003)
  • J.J. Goronzy et al.

    T cell development and receptor diversity during aging

    Curr. Opin. Immunol.

    (2005)
  • A.W. Goldrath et al.

    Selecting and maintaining a diverse T-cell repertoire

    Nature

    (1999)
  • D.C. Macallan et al.

    Rapid turnover of effector-memory CD4(+) T cells in healthy humans

    J. Exp. Med.

    (2004)
  • D.C. Douek et al.

    Changes in thymic function with age and during the treatment of HIV infection

    Nature

    (1998)
  • B.F. Haynes et al.

    The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection

    Annu. Rev. Immunol.

    (2000)
  • K. Koetz et al.

    T cell homeostasis in patients with rheumatoid arthritis

    Proc. Natl. Acad. Sci. U. S. A.

    (2000)
  • F.T. Hakim et al.

    Age-dependent incidence, time course, and consequences of thymic renewal in adults

    J. Clin. Invest.

    (2005)
  • Cited by (345)

    • Proteostasis in T cell aging

      2023, Seminars in Immunology
    • T cell control of inflammaging

      2023, Seminars in Immunology
    View all citing articles on Scopus
    View full text